Get the Stockscreener App
44.57
6.12%
2.57
After Hours:
45.00
0.43
+0.96%
Anbio Biotechnology stock is traded at $44.57, with a volume of 119.24K.
It is up +6.12% in the last 24 hours and up +40.78% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$42.00
Open:
$41.8
24h Volume:
119.24K
Relative Volume:
1.05
Market Cap:
$1.96B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.34%
1M Performance:
+40.78%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$41.80
$45.07
1-Week Range:
$41.46
$54.34
52-Week Range:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
44.57 | 1.84B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Anbio Biotechnology Stock (NNNN) Latest News
Why Anbio Biotechnology stock attracts strong analyst attentionLong Term Equity Screener with Safety Metrics - Newser
Alnylam Pharmaceuticals Skyrocketed 16.26%—Can This Biotech Breakout Sustain Momentum? - AInvest
Risk vs reward if holding onto Anbio BiotechnologyMarket Forecast Summary Over Multi-Year Period - Newser
Why Churchill Capital Corp IX stock attracts strong analyst attentionAutomated AI Forecast with Trading Alerts - Newser
Using fundamentals and technicals on CDNSFree Daily Picks With Predictable Performance - Newser
Anbio Biotechnology Plunges 8.67%, What Storm Is Brewing in the Diagnostics Sector? - AInvest
Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest
Is Anbio Biotechnology Stock a Smart Buy in 2025 Investment Analysis InsideYield Curve Outlook and Long-Term Implication Summary - Newser
What makes Anbio Biotechnology stock price move sharplyShort-Term Stock Trend Forecast Guide - Newser
Institutional scanner results for Anbio BiotechnologyFree AI Driven Buy Alert Trade Blueprint - Newser
Anbio Biotechnology Trading Near Value Zone — Recovery AheadPattern Detection for Entry Confirmation Enabled - metal.it
Technical signs of recovery in Anbio BiotechnologyAI Powered Buy Point Forecast Planner - Newser
How high can ICMB stock price go in 2025Free Early Breakout Entry Point Notifications - Newser
Comparing Anbio Biotechnology in custom built stock radarsConservative Investment Setup and Risk Analysis - Newser
Published on: 2025-07-29 19:40:19 - metal.it
How Net Lease Office Properties stock performs during market volatilityRSI Divergence and Support Breakout Analysis - Newser
Using data models to predict CLPT stock movementFree Oversold Recovery Opportunity Stocks - Newser
Will breakout in Anbio Biotechnology lead to full recoveryShort-Term Sector Movement Forecast Generator - Newser
Buy Signal for KEQU Stock Key Technical Indicators to WatchFree Market Momentum and Signal Alerts - Newser
Is it the right time to buy Sight Sciences Inc. stockStock Market Updates For Beginners - jammulinksnews.com
What are Anbio Biotechnology company’s key revenue driversEarnings Report Outlook For 2025 - jammulinksnews.com
Is Anbio Biotechnology a growth stock or a value stockUnlock powerful trading tools for investors - jammulinksnews.com
What are analysts’ price targets for Anbio Biotechnology in the next 12 monthsPowerful profit generation - jammulinksnews.com
Does Anbio Biotechnology stock perform well during market downturnsOutstanding trading profits - jammulinksnews.com
What is the dividend policy of Anbio Biotechnology stockUnlock powerful trading signals and alerts - jammulinksnews.com
How Resilient Is Anbio Biotechnology Stock During Economic DownturnsFree Stock Market Query - metal.it
Avidity Biosciences Skyrocketed 11.29% – What’s Fueling This Biotech Surge? - AInvest
What drives SBXD.U stock priceExceptional market positioning - PrintWeekIndia
How Anbio Biotechnology stock reacts to Fed policy changesExplosive portfolio gains - jammulinksnews.com
Passage Bio Soars 12.39% on Institutional Buying Spree - AInvest
What drives Anbio Biotechnology stock priceHigh-yield investments - PrintWeekIndia
Why Anbio Biotechnology stock is on top investor watchlistsMassive portfolio appreciation - jammulinksnews.com
Published on: 2025-07-25 04:34:44 - jammulinksnews.com
Anbio Biotechnology Surged 9.5%—Is a Breakout in Scientific Innovation Fueling This Rally? - AInvest
Anbio Biotechnology Stock Analysis and ForecastMarket-beating performance - Autocar Professional
INmune Bio Skyrockets 27.1%: What's Fueling This Biotech Volatility? - AInvest
Arrowhead Pharmaceuticals Soars 9.02%—What’s Fueling This Volatile Surge? - AInvest
What analysts say about Anbio Biotechnology stockHigh-octane gains - jammulinksnews.com
What drives HAIN stock priceHigh-octane gains - jammulinksnews.com
Anbio Biotechnology Plunges 19.12% Intraday, Can This Freefall Signal a Sector-Wide Crisis? - AInvest
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):